Back to Journals » Journal of Hepatocellular Carcinoma » Volume 10

Efficacy and Safety of TACE Combined with Lenvatinib and PD-(L)1 Inhibitor in the Treatment of Unresectable Hepatocellular Carcinoma: A Retrospective Study

Total article views   HTML views PDF downloads Totals
1,731 Dovepress* 1,636+ 44 1,680
PubMed Central* 95 77 172
Totals 1,731 121 1,852
*Since 5 September 2023

View citations on PubMed Central and Google Scholar